These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 24262330
1. Survivin messenger RNA levels in Epstein-Barr virus-positive patients with leukemic low-grade B-cell lymphomas expressing the latent membrane protein 1: evidence of apoptotic function? Diamantopoulos PT, Polonyfi K, Sofotasiou M, Mantzourani M, Galanopoulos A, Spanakis N, Papadopoulou V, Kalala F, Iliakis T, Zareifi DS, Kodandreopoulou E, Vassilakopoulos T, Angelopoulou M, Siakantaris M, Terpos E, Variami E, Kollia P, Vaiopoulos G, Pangalis G, Viniou NA. Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):56-60. PubMed ID: 24262330 [Abstract] [Full Text] [Related]
7. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL. Kanemitsu N, Isobe Y, Masuda A, Momose S, Higashi M, Tamaru J, Sugimoto K, Komatsu N. Clin Cancer Res; 2012 Apr 15; 18(8):2164-72. PubMed ID: 22371452 [Abstract] [Full Text] [Related]
8. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1. Peng M, Lundgren E. Leukemia; 1993 Jan 15; 7(1):104-12. PubMed ID: 8093369 [Abstract] [Full Text] [Related]
9. Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1. Zhou H, Guo W, Long C, Wang H, Wang J, Sun X. Biochem Biophys Res Commun; 2015 Jan 16; 456(3):815-20. PubMed ID: 25511707 [Abstract] [Full Text] [Related]
10. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies. Demachi-Okamura A, Ito Y, Akatsuka Y, Tsujimura K, Morishima Y, Takahashi T, Kuzushima K. Eur J Immunol; 2006 Mar 16; 36(3):593-602. PubMed ID: 16479544 [Abstract] [Full Text] [Related]
11. Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases. Bernasconi M, Ueda S, Krukowski P, Bornhauser BC, Ladell K, Dorner M, Sigrist JA, Campidelli C, Aslandogmus R, Alessi D, Berger C, Pileri SA, Speck RF, Nadal D. Int J Cancer; 2013 Nov 15; 133(10):2341-50. PubMed ID: 23640782 [Abstract] [Full Text] [Related]
12. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. Liebowitz D. N Engl J Med; 1998 May 14; 338(20):1413-21. PubMed ID: 9580648 [Abstract] [Full Text] [Related]
13. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis. Ma SD, Xu X, Plowshay J, Ranheim EA, Burlingham WJ, Jensen JL, Asimakopoulos F, Tang W, Gulley ML, Cesarman E, Gumperz JE, Kenney SC. J Clin Invest; 2015 Jan 14; 125(1):304-15. PubMed ID: 25485679 [Abstract] [Full Text] [Related]
14. Rituximab in the treatment of EBV-positive low grade B-cell lymphoma. Diamantopoulos PT, Polonyfi K, Sofotasiou M, Papadopoulou V, Kalala F, Iliakis T, Zervakis K, Tsilimidos G, Kouzis P, Kyrtsonis MC, Vassilakopoulos T, Angelopoulou M, Siakantaris M, Vayopoulos G, Kollia P, Pangalis G, Viniou NA. Anticancer Res; 2013 Dec 14; 33(12):5693-8. PubMed ID: 24324119 [Abstract] [Full Text] [Related]
15. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT, Fernandes BJ, Mock D. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug 14; 92(2):184-93. PubMed ID: 11505266 [Abstract] [Full Text] [Related]
16. Involvement of Epstein-Barr virus (EBV)-encoded latent membrane protein (LMP)-1 in the potentiation of C epsilon mRNA expression in human tonsil-derived cells. Ohta S, Hanashiro K, Sunagawa M, Tono T, Suzuki M, Kosugi T. Eur Arch Otorhinolaryngol; 2007 Mar 14; 264(3):245-50. PubMed ID: 17089136 [Abstract] [Full Text] [Related]
17. Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency III. Messinger JE, Dai J, Stanland LJ, Price AM, Luftig MA. mBio; 2019 Jul 02; 10(4):. PubMed ID: 31266868 [Abstract] [Full Text] [Related]
18. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment. Shields DJ, Byrd JC, Abbondanzo SL, Lichy JH, Diehl LF, Aguilera NI. Mod Pathol; 1997 Nov 02; 10(11):1151-9. PubMed ID: 9388067 [Abstract] [Full Text] [Related]
19. Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein-Barr virus-positive patients with chronic lymphocytic leukemia. Diamantopoulos PT, Sofotasiou M, Georgoussi Z, Giannakopoulou N, Papadopoulou V, Galanopoulos A, Kontandreopoulou E, Zervakis P, Pallaki P, Kalala F, Kyrtsonis MC, Dimitrakopoulou A, Vassilakopoulos T, Angelopoulou M, Spanakis N, Viniou NA. Cancer Med; 2016 Sep 02; 5(9):2240-8. PubMed ID: 27367207 [Abstract] [Full Text] [Related]
20. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma. Knecht H, Martius F, Bachmann E, Hoffman T, Zimmermann DR, Rothenberger S, Sandvej K, Wegmann W, Hurwitz N, Odermatt BF. Leukemia; 1995 Mar 02; 9(3):458-65. PubMed ID: 7885044 [Abstract] [Full Text] [Related] Page: [Next] [New Search]